Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19
In this medfyle
Evolving care in a post-pandemic world.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Expert commentary
About this Medfyle
This summary is based upon an article appearing in the journal entitled The Journal of Clinical Endocrinology & Metabolism published by Oxford University Press and was created by GlobalPort. Oxford University Press takes no responsibility for its accuracy or for the use of any content therein by those reading or downloading such content.
The summary content was prepared by Marie Farrow for Medfyle, reviewed & approved by Raghu G. Mirmira, MD, PhD.
Original article:
Shivani Agarwal, Michelle L Griffith, Elizabeth J Murphy, Carol Greenlee, Jeffrey Boord, Robert A Gabbay, for the Innovative Models of Diabetes Care Taskforce of the Endocrine Society, Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19, The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 1, January 2021, Pages e377–e381, https://doi.org/10.1210/clinem/dgaa704
The authors of the original article had no part in the creation of the summary.
All Medfyle content, summaries, expert commentaries and slides are owned by GlobalPort (International) Limited. The original journal articles are an exclusive copyright of Endocrine Society/Oxford University Press.
This activity is supported by an educational grant from Lilly.
